L-Carnitine 600mg

Reconstitution

For peptides supplied as lyophilised powder, reconstitute in bacteriostatic water or sterile saline at the concentration appropriate to your protocol. Allow the vial to come to room temperature before opening, add solvent slowly down the inside wall (do not directly onto the powder), and gently invert until clear. Do not vortex.

Reconstituted solutions are typically stable at 2–8°C for the durations published in the corresponding peer-reviewed reference. For long-term storage, aliquot and freeze at −20°C; avoid repeated freeze–thaw cycles.

Open the full reconstitution guide

Research literature

Selected peer-reviewed publications from PubMed referencing this compound. Provided for research orientation — not an endorsement of any clinical application. Each citation links to the canonical PubMed record.

1. Significance of Levocarnitine Treatment in Dialysis Patients.
   Takashima H et al. · Nutrients · 2021
   PubMed PMID 33917145
2. Levocarnitine for valproic-acid-induced hyperammonemic encephalopathy.
   Mock CM et al. · American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists · 2012
   PubMed PMID 22180549
3. Vitamin E and levocarnitine as prophylaxis against doxorubicin-induced cardio toxicity in the adult cancer patient: A review.
   Moustafa I et al. · Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners · 2022
   PubMed PMID 35139690

Citations selected by PubMed relevance ranking for the search term Levocarnitine.